H
Henlius is a rapidly growing biopharmaceutical provider that develops, manufactures, and distributes leading oncology treatments. Our talented team brings experience from all sectors of the pharmaceutical industry to deliver more effective and affordable treatments for over 700,000 patients in over 50 countries. Our mission is to provide effective treatments in oncology and other diseases that allow people regain their healthy lives. Learn more at www.henlius.com/en/Index.html
Investor insights
Funding rounds participated in
$156M sweet spot round size
Investor type
Public Company
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Date founded
2010
Funding rounds raised
Total raised
$156M
from investors over 1 rounds
H
Henlius raised $156M on August 20, 2018